Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04275934
Other study ID # 020
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 6, 2020
Est. completion date December 31, 2020

Study information

Verified date February 2023
Source American Pharmacists Association Foundation
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The primary objective of this project is to improve the health status of participants through pharmacist-delivered blood pressure control programs that demonstrate value to employers and justify adoption, sustainability and scalability of these programs.


Description:

Univariate comparisons of the baseline/pre-intervention outcomes to the post-intervention outcomes will be performed on outcomes in order to determine how the intervention affects each. For continuous outcomes data the univariate comparisons of the pre-treatment and post-intervention outcomes will be performed using related samples t-test comparisons. For categorical outcomes data, comparisons of pre-intervention to post-intervention time frames will be performed using McNemar tests.


Recruitment information / eligibility

Status Completed
Enrollment 27
Est. completion date December 31, 2020
Est. primary completion date July 31, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - All health plan beneficiaries 18 years-of-age and older - Have filled at least one blood pressure medication in the last three months, - Have a known hypertension diagnosis or have an uncontrolled blood pressure Exclusion Criteria: - Not an adult - Not a health plan beneficiary of the self-insured employer - Not ambulatory and able to work or participate in care visits

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Health Management; Blood Pressure
Pharmacists will work with the patient/study subject, referred to as the participant hereafter, and the participant's other health care providers to manage their blood pressure, making recommendations for medication and lifestyle adjustments as needed.

Locations

Country Name City State
United States Woodstock Pharmaceutical & Compounding Center Inc. Woodstock Georgia

Sponsors (1)

Lead Sponsor Collaborator
American Pharmacists Association Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood Pressure Control Management of Systolic and Diastolic Blood Pressure Measures 6-months
Primary Blood Pressure Change Systolic and Diastolic Blood Pressure Measure Changes 6-months
Secondary Blood Pressure Medication Adherence Medication Adherence for Blood Pressure Medications as Measured by Proportion of Days Covered (PDC) 6-months
Secondary Health Care Utilization of Primary Care Services Evaluation of Pre- and Post-Intervention Frequency of Primary Health Care Visits 6-months
Secondary Health Care Utilization of Emergency Department Services Evaluation of Pre- and Post-Intervention Frequency Emergency Department Visits 6-months
Secondary Health Care Utilization of Hospital Services Evaluation of Pre- and Post-Intervention Frequency of Hospital Visits 6-months
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A